ActiveMSers Forums  

Go Back   ActiveMSers Forums > Search Forums

Showing results 1 to 7 of 7
Search took 0.00 seconds.
Search: Posts Made By: thumbsup
Forum: General 03-27-2010, 02:59 AM
Replies: 1
Views: 2,264
Posted By thumbsup
Low dose naltrexone (LDN) study released, results mixed

Results of a phase II clinical trial on the safety and effectiveness of low dose naltrexone (LDN) as a symptom-relief treatment for people with MS have been published in the journal Annals of...
Forum: General 03-23-2010, 05:05 PM
Replies: 0
Views: 1,987
Posted By thumbsup
Italian Researchers Discover A Possible Onset Mechanism For Multiple Sclerosis

Hi, read this,

A non-pathogenic bacterium is capable of triggering an autoimmune disease similar to multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work....
Forum: General 03-20-2010, 05:28 AM
Replies: 0
Views: 1,928
Posted By thumbsup
Copaxone(R) 15-Year Study In Multiple Sclerosis Patients Demonstrates....

Hi, I read about this today.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced the publication of data from the 15-year clinical study with CopaxoneŽ (glatiramer acetate injection), which...
Forum: MS Fitness 03-15-2010, 03:11 AM
Replies: 1
Views: 2,489
Posted By thumbsup
Migraine More Common In Women With MS

Migraine is seen more frequently in women with multiple sclerosis (MS) than those without, according to a study released today that will be presented at the American Academy of Neurology's 62nd...
Forum: World Region 03-14-2010, 12:34 PM
Replies: 0
Views: 2,688
Posted By thumbsup
MS Society Launches Major Manifesto Campaign, UK

Today the MS Society launches its 2010 Manifesto in a serious and high profile attempt to encourage the next Government to act upon MS inequalities.

The document sets 10 powerful calls for the next...
Forum: General 03-08-2010, 03:48 AM
Replies: 0
Views: 2,073
Posted By thumbsup
Add-On Daclizumab Treatment May Be Better In Reducing Multiple Sclerosis

Have you read this,
An article published Online First and in the April edition of The Lancet Neurology reports that add-on daclizumab treatment might reduce multiple sclerosis disease activity more...
Forum: General 03-05-2010, 12:04 PM
Replies: 1
Views: 2,270
Posted By thumbsup
Promising Results In First Blinded Study Of Venous Insufficiency Prevalence In MS

Have you read about this,
More than 55 percent of multiple sclerosis patients participating in the initial phase of the first randomized clinical study to determine if persons with MS exhibit...
Showing results 1 to 7 of 7

Forum Jump

All times are GMT -4. The time now is 06:32 AM.

Powered by vBulletin® Version 3.7.0
Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.